News-Medical.Net August 14, 2024
Dr. Chinta Sidharthan

In a recent study published in The Lancet Regional Health – Americas, researchers evaluated whether the various coronavirus disease 2019 (COVID-19) vaccine rollout phases impacted the prevalence of depression and anxiety at the population level among adults in the country.

Background

A plethora of studies since the onset of the COVID-19 pandemic have reported that socio-economic and health-related disparities have been exacerbated for numerous individuals and families in the U.S. due to the pandemic. Evidence from substantial research suggests that the pandemic has had multi-faceted effects on mental health.

The compounded stressors of high morbidity and mortality rates associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the social distancing and isolation protocols initiated by the government as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Mental Health, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Private Equity Investors Are Still Laser-Focused on Behavioral Health Care
Private Equity in Behavioral Health: Compliance Champions or Cost-Cutting Villains?
Private equity-backed company acquires New York behavioral provider
Beyond Stigma: Why Addressing Maternal Mental Health Means Confronting Systemic Failures
Prisma Health triples access to behavioral health services

Share This Article